Elixirr International (LON:ELIX) Trading Down 1.6% – Should You Sell?

Elixirr International plc (LON:ELIX)’s share price traded down 1.6% during mid-day trading on Friday . The stock traded as low as GBX 620 and last traded at GBX 620. Approximately 43,359 shares were traded during trading, a decline of 61% from the average daily volume of 111,391 shares. The stock had previously closed at GBX 630.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank reiterated a “buy” rating and set a GBX 1,060 price objective on shares of Elixirr International in a research note on Monday, April 20th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Elixirr International has a consensus rating of “Buy” and an average target price of GBX 1,060.

Elixirr International Trading Down 1.6%

The company has a 50 day moving average of GBX 686.45 and a two-hundred day moving average of GBX 703.46. The company has a debt-to-equity ratio of 23.52, a quick ratio of 1.29 and a current ratio of 0.52. The stock has a market capitalization of £307.28 million, a PE ratio of 16.68 and a beta of 0.67.

Insiders Place Their Bets

In other Elixirr International news, insider Nick Willott sold 6,410 shares of the firm’s stock in a transaction dated Thursday, July 9th. The stock was sold at an average price of GBX 680, for a total value of £43,588. Corporate insiders own 33.03% of the company’s stock.

Elixirr International Company Profile

Elixirr is a global consulting firm with a bold ambition: to become the best consulting firm in the world.

Founded in 2009 to challenge a declining industry standard, we’ve grown from a single vision into a powerhouse of entrepreneurial talent. We partner with businesses around the world to deliver transformational results, from boardroom strategy through to execution, powered by the technology of tomorrow. We do this in a way that’s anything but traditional – helping our clients change the game in their industries, just as we are changing the game in ours.